FDA clears No­vavax’s fall boost­er for Covid-19, weeks af­ter mR­NA vac­cine boost­ers 

The FDA cleared No­vavax’s up­dat­ed Covid-19 boost­er for the fall sea­son on Tues­day, weeks af­ter mR­NA boost­ers se­cured an au­tho­riza­tion.

No­vavax made clear last month that dos­es had ar­rived in the US and were ready to ship. How­ev­er, reg­u­la­tors made no men­tion of the boost­er in a Sept. 11 an­nounce­ment clear­ing up­dat­ed shots from both Pfiz­er/BioN­Tech and Mod­er­na.

At the time, a No­vavax spokesper­son said the com­pa­ny was “cur­rent­ly re­spond­ing to the FDA’s re­quests to fa­cil­i­tate fi­nal re­view.” Shares of No­vavax stock rose 11% on Tues­day fol­low­ing the EUA.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER